Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CMV-CD19 CAR T-cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
CMV-CD19 CAR T-cells are CMV-specific T-cells that are engineered to express a chimeric antigen receptor (CAR) targeting CD19, which may stimulate an anti-tumor response against CD19-expressing tumors (PMID: 35027426, PMID: 25838392). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CMV-CD19 CAR T-cells | CMV-CD19 CAR T-cells | 0 | 0 |
CMV-CD19 CAR T-cells + Multi-antigen CMV-modified vaccinia Ankara vaccine | CMV-CD19 CAR T-cells Multi-antigen CMV-modified vaccinia Ankara vaccine | 0 | 1 |